Inhibitor selectivity of a new class of oseltamivir analogs against viral neuraminidase over human neuraminidase enzymes (original) (raw)
Three new powerful oseltamivir derivatives for inhibiting the neuraminidase of influenza virus
Xian-Chao Cheng
Biochemical and Biophysical Research Communications, 2010
View PDFchevron_right
Optimization of N-Substituted Oseltamivir Derivatives as Potent Inhibitors of Group-1 and -2 Influenza A Neuraminidases, Including a Drug-Resistant Variant
Peng Zhan
Journal of medicinal chemistry, 2018
View PDFchevron_right
Discovery of C-1 modified oseltamivir derivatives as potent influenza neuraminidase inhibitors
Han Ju
European journal of medicinal chemistry, 2018
View PDFchevron_right
Design of oseltamivir analogs inhibiting neuraminidase of avian influenza virus H5N1
S. Miertus, Vladimir Frecer
Antiviral Research, 2009
View PDFchevron_right
In silico modification of oseltamivir as neuraminidase inhibitor of influenza A virus subtype H1N1
Arli Parikesit
View PDFchevron_right
Molecular Docking studies on possible Neuraminidase Inhibitors of Influenza Virus
Jawaria Khan
Annals of Antivirals and Antiretrovirals, 2017
View PDFchevron_right
BCX-1812 (RWJ-270201): Discovery of a Novel, Highly Potent, Orally Active, and Selective Influenza Neuraminidase Inhibitor through Structure-Based Drug Design
ali dehghani
Journal of Medicinal Chemistry, 2000
View PDFchevron_right
Potent and long-acting dimeric inhibitors of influenza virus neuraminidase are effective at a once- …
Van linh Nguyen
Antimicrobial agents and chemotherapy, 2004
View PDFchevron_right
In Vitro Characterization of A-315675, a Highly Potent Inhibitor of A and B Strain Influenza Virus Neuraminidases and Influenza Virus Replication
L. Gubareva
Antimicrobial Agents and Chemotherapy, 2002
View PDFchevron_right
Novel aromatic inhibitors of influenza virus neuraminidase make selective interactions with conserved residues and water molecules in the active site 1 1Edited by I. A. Wilson
Franco duarte
Journal of Molecular Biology, 1999
View PDFchevron_right
Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase
Jennifer McKimm-breschkin
Structure, 1998
View PDFchevron_right
Structure-Based Optimization of N-Substituted Oseltamivir Derivatives as Potent Anti-influenza A Virus Agents with Significantly Improved Potency against Oseltamivir-Resistant N1-H274Y Variant
Peng Zhan
Journal of medicinal chemistry, 2018
View PDFchevron_right
Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants
john skehel
Nature, 2008
View PDFchevron_right
Structure-aided drug development of potential neuraminidase inhibitors against pandemic H1N1 exploring alternate binding mechanism
Anand S Chintakrindi
Molecular Diversity
View PDFchevron_right
Inhibition of viral group-1 and group-2 neuraminidases by oseltamivir: A comparative structural analysis by the ScrewFit algorithm
G. Kneller
Biophysical Chemistry, 2009
View PDFchevron_right
Search for novel neuraminidase inhibitors: Design, synthesis and interaction of oseltamivir derivatives with model membrane using docking, NMR and DSC methods
Evans Coutinho
Biochimica et Biophysica Acta (BBA) - Biomembranes, 2009
View PDFchevron_right
Analysis of inhibitor binding in influenza virus neuraminidase
Mark Von Itzstein
Protein Science, 2001
View PDFchevron_right
Potent and Long-Acting Dimeric Inhibitors of Influenza Virus Neuraminidase Are Effective at a Once-Weekly Dosing Regimen
David Chalmers
Antimicrobial Agents and Chemotherapy, 2004
View PDFchevron_right
Structural analysis of the novel influenza A (H7N9) viral Neuraminidase interactions with current approved neuraminidase inhibitors Oseltamivir, Zanamivir, and Peramivir in the presence of mutation R289K
Tran Su
BMC Bioinformatics, 2013
View PDFchevron_right
Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidase
Rob Fenton
Bioorganic & Medicinal Chemistry Letters, 2004
View PDFchevron_right
Identification of neuraminidase inhibitors against dual H274Y/I222R mutant strains
Nikhil Pathak
Scientific Reports, 2017
View PDFchevron_right
Cyclopentane Neuraminidase Inhibitors with Potent In Vitro Anti-Influenza Virus Activities
John Huffman
Antimicrobial Agents and Chemotherapy, 2001
View PDFchevron_right
Design, Synthesis, and Anti-influenza Viral Activities of 1,3-Diarylprop- 2-en-1-ones: A Novel Class of Neuraminidase Inhibitors
Mayank Kinger
View PDFchevron_right
Efficacy of the New Neuraminidase Inhibitor CS-8958 against H5N1 Influenza Viruses
Chairul Anwar Nidom
PLoS Pathogens, 2010
View PDFchevron_right
Recent progress in chemical approaches for the development of novel neuraminidase inhibitors
Venkataramana Kandi
View PDFchevron_right
Activity of the Oral Neuraminidase Inhibitor A-322278 against the Oseltamivir-Resistant H274Y (A/H1N1) Influenza Virus Mutant in Mice
Mariana Baz
Antimicrobial Agents and Chemotherapy, 2008
View PDFchevron_right
Structural and Functional Basis of Resistance to Neuraminidase Inhibitors of Influenza B Viruses
Aaron Oakley
Journal of Medicinal Chemistry, 2010
View PDFchevron_right
Design, Synthesis, and Molecular Docking of Novel Pyrrolooxazepinediol Derivatives with Anti-Influenza Neuraminidase Activity
Ahmad F Eweas
View PDFchevron_right